Conjugates for treating diseases caused by PSMA expressing cells
US-9636413-B2 · May 2, 2017 · US
Metal salen complex derivative and process for production thereof
US9603940B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9603940-B2 |
| Application number | US-201113639656-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 6, 2011 |
| Priority date | Apr 6, 2010 |
| Publication date | Mar 28, 2017 |
| Grant date | Mar 28, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A metal-salen complex derivative with an excellent yield and stability is provided and a method for producing such a metal-salen complex derivative is provided. The present invention provides: metal-salen complex derivative obtained by allowing a target component composed of at least one of an enzyme, an antibody, an antigen, a peptide, an amino acid, an oligonucleotide, a protein, a nucleic acid, and a medical molecule to bind to a metal-salen complex via an amide bond or a disulfide bond; a method for producing such a metal-salen complex derivative.
First claim
Opening claim text (preview).
The invention claimed is: 1. An iron-salen complex derivative of formula 2. A method of producing an iron-salen complex derivative of formula the method comprising binding a functional molecule to an iron salen complex via a bond area, wherein: the functional molecule is papain; the iron salen complex is and the bond area is
Assignees
Inventors
Classifications
Medicinal preparations obtained by treating materials with wave energy or particle radiation {; Therapies using these preparations} · CPC title
- A61K47/547Primary
Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent · CPC title
involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis · CPC title
Antineoplastic agents · CPC title
- A61K47/48076Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9603940B2 cover?
- A metal-salen complex derivative with an excellent yield and stability is provided and a method for producing such a metal-salen complex derivative is provided. The present invention provides: metal-salen complex derivative obtained by allowing a target component composed of at least one of an enzyme, an antibody, an antigen, a peptide, an amino acid, an oligonucleotide, a protein, a nucleic ac…
- Who is the assignee on this patent?
- Ishikawa Yoshihiro, Eguchi Haruki, Sato Hiroshi, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K47/547. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).